What Are Pyrimidine Dimers? Causes, Effects, and Repair

Pyrimidine dimers are abnormal bonds that form between two neighboring pyrimidine bases in a DNA strand when ultraviolet light forces them to fuse together. The two main types are cyclobutane pyrimidine dimers (CPDs) and (6-4) photoproducts, with CPDs being far more common and more consequential for human health. These lesions distort the DNA helix, stall the machinery that copies and reads genetic information, and, if left unrepaired, introduce the specific pattern of mutations most strongly linked to skin cancer.

How UV Light Creates Pyrimidine Dimers

DNA contains four bases, two of which are pyrimidines: cytosine (C) and thymine (T). When two pyrimidines sit next to each other on the same DNA strand, UV photons can supply enough energy to force covalent bonds between them, locking the two bases into a fused structure. In a CPD, the bases link through a four-membered carbon ring. In a (6-4) photoproduct, the bond forms between different positions on the two bases, creating a more pronounced kink in the helix.

The wavelength of UV light matters enormously. Research on human skin found that the peak efficiency for pyrimidine dimer formation is near 300 nm, right in the UVB range, and drops off sharply at both longer and shorter wavelengths.¹ Laser irradiation studies across a continuous spread of wavelengths confirmed that CPDs and (6-4) photoproducts form in a wavelength-dependent pattern driven by direct UV absorption by DNA itself.²

UVA radiation, which makes up roughly 95% of the UV light reaching Earth’s surface, was long assumed to cause damage mainly through oxidative stress rather than by directly producing dimers. That assumption turned out to be wrong. Quantitative analysis of whole human skin exposed to UVA showed that CPDs form in significant amounts, and they actually outnumber the most common oxidative DNA lesion (8-oxoguanine) in UVA-irradiated skin.³ The ratio is striking: at biologically relevant UVA doses, CPDs outnumber oxidized purines by roughly ten to one, and UVA generates CPDs with a strong preference for thymine-thymine sequences, which points to a photosensitized energy-transfer mechanism rather than direct photon absorption.⁴ Unlike UVB, UVA does not produce (6-4) photoproducts at all.

Dimers That Form in the Dark

One of the more unsettling discoveries in this field came from a 2015 study showing that melanocytes, the pigment-producing cells in skin, keep generating CPDs for more than three hours after UVA exposure has ended. These “dark CPDs” account for the majority of dimers in melanocytes and include the cytosine-containing dimers that seed the characteristic C-to-T mutations linked to skin cancer.⁵

The mechanism is remarkable. UV-generated reactive oxygen and nitrogen species interact with fragments of melanin, the skin pigment itself, to create a chemically excited state with the energy equivalent of a UV photon. That excited state then transfers its energy to DNA, producing CPDs without any light involved. The implication is that melanin, long thought of purely as a protective sunscreen, has a dark side: it can act as a delayed source of DNA damage even after you have left the sun or the tanning bed.

What Pyrimidine Dimers Do to Cells

A pyrimidine dimer sitting in your DNA is like a roadblock. It interferes with the two most critical things your cells do with their genetic code: copying it and reading it.

During DNA replication, a high-fidelity DNA polymerase encounters the fused bases and essentially gets no useful template information from them. Structural studies show that the dimer cannot move into the enzyme’s insertion site properly, which misaligns the incoming building block relative to the growing DNA strand. The distance between the primer and the incoming nucleotide increases from a normal working distance to one that prevents the chemical reaction from proceeding, effectively stalling the replication fork.⁶

Transcription, the process of reading DNA to produce RNA, runs into the same problem. RNA polymerase II can incorporate a couple of nucleotides opposite a CPD or (6-4) photoproduct but then stalls, forming a stuck complex on the damaged DNA.⁷ If enough genes are blocked this way, the cell loses the ability to produce essential proteins and may trigger its own death through apoptosis.

When dimers are not repaired before replication, the consequences show up as mutations. The hallmark is the C-to-T transition at dipyrimidine sites, which has been confirmed in both tumor tissues and cell culture experiments.⁸ A confirmed UV mutation signature requires at least 60% of mutations to be C-to-T changes at dipyrimidine sites, with at least 5% being tandem CC-to-TT changes. This pattern is so consistent that researchers use it as a fingerprint to identify tumors caused by sunlight exposure.

How Cells Fix Pyrimidine Dimers

Cells have evolved several strategies for dealing with pyrimidine dimers, and the relative importance of each strategy differs across species.

Photoreactivation

The oldest known repair mechanism, discovered in the late 1940s by Albert Kelner and independently by Renato Dulbecco, uses an enzyme called photolyase that literally reverses the damage using blue light.⁹ Photolyase binds to the dimer, absorbs a blue-light photon, and uses that energy to send an electron into the fused bases, breaking the abnormal bonds and restoring the original bases. The electron then returns to the enzyme, making the whole process a true catalytic cycle with no net consumption of anything except light energy.¹⁰ The entire reaction, from photon absorption to restored DNA, takes about one nanosecond.¹¹

Photoreactivation is widespread in bacteria, plants, fungi, and many animals. However, placental mammals, including humans, lost functional photolyase genes during evolution. We rely entirely on other repair pathways.

Nucleotide Excision Repair

Nucleotide excision repair (NER) is the main defense against pyrimidine dimers in human cells. Rather than reversing the damage directly, NER cuts out a stretch of about 24 to 32 nucleotides from the damaged strand and fills the gap using the undamaged complementary strand as a template.¹² The process involves dozens of proteins working in sequence to recognize the distortion, unwind the helix, cut on both sides of the lesion, remove the fragment, and reseal the strand.

NER operates in two flavors. Global genome repair (GG-NER) scans the entire genome for helix-distorting damage. Transcription-coupled repair (TC-NER) is triggered specifically when RNA polymerase II stalls at a lesion in a gene that is actively being read. TC-NER tends to be faster because the stalled polymerase itself serves as the damage signal, prioritizing the repair of genes the cell is currently using.

Translesion Synthesis

Sometimes a replication fork reaches a dimer before NER can fix it. In that case, the cell can swap in a specialized, more flexible polymerase to copy across the damage. Human DNA polymerase eta (Pol eta) can replicate past thymine-thymine CPDs with surprisingly high accuracy.¹³ Studies in both mouse and human cells show that Pol eta performs essentially error-free bypass of CPDs, and that the UV mutations people worry about actually arise when other, less accurate polymerases like Pol kappa and Pol zeta handle the bypass instead.¹⁴

Recent work adds a twist: much of the mutagenicity of UV light stems not from errors during replication but from the chemical deamination of cytosine within CPDs. Cytosine spontaneously loses an amino group over time, converting to uracil, which is then read as thymine during replication. Pol eta faithfully copies this altered base, producing a C-to-T mutation not because the polymerase is sloppy but because the dimer itself has chemically changed before being copied.¹⁵

Xeroderma Pigmentosum and Cockayne Syndrome

The consequences of defective pyrimidine dimer repair are starkly visible in two genetic disorders. Xeroderma pigmentosum (XP) is caused by mutations in any of several genes in the NER pathway, leaving patients with extreme sun sensitivity and a dramatically elevated skin cancer risk. Updated estimates put the lifetime increase at roughly 10,000-fold for non-melanoma skin cancers and about 2,000-fold for melanoma compared to the general population.¹⁶ About half of XP patients also experience pronounced photosensitivity and some subtypes develop progressive neurological problems or eye disease, depending on which NER gene is affected.

A variant form of XP, called XP-V, specifically involves the gene encoding Pol eta. These patients can perform NER normally but cannot do accurate translesion synthesis past CPDs. The result is that less reliable polymerases handle the bypass, leading to more mutations and elevated cancer rates.¹⁵

Cockayne syndrome (CS) involves defects in the transcription-coupled branch of NER, caused by mutations in the CSA or CSB genes.¹⁷ The CSB protein appears to play a dual role, being involved in both repair and normal transcription.¹⁸ Unlike XP, Cockayne syndrome does not greatly increase cancer risk but instead causes growth failure, neurological degeneration, and premature aging. The reason for this difference remains an active research question, but it likely relates to CS cells being more prone to triggering cell death when transcription is blocked, clearing damaged cells before they can become cancerous but at the cost of tissue function.

Pyrimidine Dimers and Skin Cancer

Among the various types of DNA damage UV light can cause, CPDs stand out as the most important driver of skin cancer. Multiple lines of evidence converge on this conclusion. Review of wavelength-dependent damage data, mutation spectra from tumors, and the molecular properties of the lesions themselves all point to CPDs rather than (6-4) photoproducts or oxidative damage as the lesion most strongly involved in human cancers caused by sunlight.⁷

For melanoma specifically, researchers used a technique called circle damage sequencing to map exactly where cytosine-containing CPDs undergo deamination across the human genome. The trinucleotide patterns surrounding those deaminated dimers matched the melanoma mutation signature with a cosine similarity between 0.83 and 0.85, providing strong mechanistic evidence that UVB-induced CPD deamination is the primary biochemical route from sunlight to melanoma mutations.¹⁹ The most mutation-prone trinucleotide contexts, such as TCC, TCA, and TCT, align precisely with the sequences where deaminated CPDs concentrate.

Pyrimidine Dimers Beyond Human Skin

The pyrimidine dimer problem is not unique to humans. Every organism exposed to UV light has to cope with this type of DNA damage, and the strategies vary widely.

Plants face constant UV exposure and rely heavily on photolyase-mediated photoreactivation, the very repair mechanism mammals have lost. They also produce UV-absorbing molecules, particularly flavonoids, that accumulate in the outer layers of their tissues and act as natural sunscreens, reducing the amount of UV that reaches the DNA in deeper cells.²⁰ These chemical sunscreens and photolyase work together: the flavonoids reduce the number of dimers formed, and photolyase repairs whatever damage gets through.²¹

Marine phytoplankton, which produce a substantial fraction of Earth’s oxygen, are particularly vulnerable because they live near the water surface where UV penetration is highest. Studies on Antarctic marine plankton found CPD levels exceeding 100 dimers per million nucleotides in surface bacterioplankton during midsummer, with the smallest cells accumulating the most damage.²² In South Atlantic picophytoplankton, limited photoreactivation capacity led to rapid CPD accumulation during daylight hours, with damage levels high enough to suggest that a proportion of cells were being killed outright.²³ These findings matter beyond marine biology: anything that reduces phytoplankton populations could cascade through marine food webs and global carbon cycles.

Some phytoplankton species do manage well. The marine alga Isochrysis galbana showed efficient DNA repair during extended sunlight exposure, with CPD levels dropping even while UV irradiation continued, indicating that repair outpaced new damage formation.²⁴

Far-UVC Germicidal Technology

Understanding pyrimidine dimer formation has practical applications beyond medicine. One of the more promising developments is far-UVC light at 222 nm, produced by filtered krypton-chloride excimer lamps. Conventional germicidal UV lamps use 254 nm light, which is excellent at killing pathogens but also penetrates human skin deep enough to cause dimers in living cells. The 222 nm wavelength is absorbed so strongly by proteins in the outermost dead layer of skin (the stratum corneum) that very little reaches the living cells beneath.

Testing in a three-dimensional human skin model found that 222 nm light killed drug-resistant bacteria efficiently while producing almost no detectable pyrimidine dimers, in contrast to the heavy dimer burden from 254 nm lamps.²⁵ The first-in-human study of filtered far-UVC confirmed these results: even at exposures 265 times the current safety limit, any CPDs that formed were restricted to the uppermost epidermal layers, with no dimer formation detected in the basal layer where skin cancers originate.²⁶

The picture is not entirely clean. Longer-term animal exposure studies suggest that 222 nm light can trigger changes in skin regeneration pathways even when dimer formation is minimal, so the technology is still being evaluated carefully.²⁷ Still, far-UVC is already being explored for use in occupied public spaces, hospital operating rooms, and other settings where airborne pathogen reduction could make a real difference.

Photolyase in Skincare Products

Since humans lack their own photolyase, some researchers and cosmetics companies have asked an obvious question: what if you put photolyase from another organism directly onto human skin? A clinical study tested a topical cream containing photolyase from a cyanobacterium, applied under a sunscreen with SPF 50, compared to the sunscreen alone. The combination of photolyase plus sunscreen was significantly better at reducing both CPD formation and apoptotic cell death in UV-irradiated human skin.²⁸

Products containing photolyase enzymes are now sold as “DNA repair” or “after-sun” creams in parts of Europe and elsewhere. The idea has biological plausibility, since photolyase only needs blue light to work and you get plenty of that outdoors. But it is worth noting that these are single studies and small trials. How well an enzyme survives in a cream formulation, how deeply it penetrates skin in real-world conditions, and whether it meaningfully reduces cancer risk over years of use remain open questions. Nobody should treat a photolyase cream as a substitute for sunscreen or shade. At best, it is an additional layer of protection layered on top of conventional measures.

Fifty Years of Thymine Dimers

The thymine dimer was discovered in the late 1950s at Delft Technological University in the Netherlands, making it the first environmentally induced DNA lesion ever identified.²⁹ The discovery of photoreactivation had actually come a decade earlier, in the late 1940s, before anyone knew what the damage was. Kelner noticed that UV-irradiated bacteria recovered much better if they were subsequently exposed to visible light, and Dulbecco independently observed the same effect in bacteriophage.⁹ It took another decade before the substrate of that mysterious light-dependent repair turned out to be the pyrimidine dimer. That sequence of events, finding the cure before identifying the disease, is unusual in science and helped catalyze the entire modern field of DNA repair research.